CHRISTINA HOLLOWAY: Open Payments
NPI 1215493119 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,114 in 39 payments from 12 companies in 2025. Trend: 2023 $848 · 2024 $1,456 · 2025 $1,114
Food & beverage: $1,114
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $176 |
| Janssen Pharmaceuticals, Inc | 4 | $168 |
| ABBVIE INC. | 5 | $152 |
| Vanda Pharmaceuticals Inc. | 6 | $150 |
| Teva Pharmaceuticals USA, Inc. | 5 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| Alkermes, Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| HARMONY BIOSCIENCES LLC | 1 | $25 |
Products named: SPRAVATO, VRAYLAR, FANAPT, AUSTEDO XR, ABILIFY MAINTENA, CAPLYTA, Auvelity, INGREZZA.
Industry payments across VA — which companies pay providers there.
